Shows
DermDocsIL-31 Mechanism of Action and Clinical Implications for Prurigo NodularisThis is the second episode of a two-part miniseries, "IL-31 Inhibition for Treatment of Prurigo Nodularis" series, supported by an educational grant from Galderma. Hosted by expert dermatologist and neuroscientist Dr. Sarina Elmariah, MD, PhD, MPH, this episode, "IL-31 Mechanism and Clinical Implications for PN", featuring Dr. Shawn Kwatra, discusses the following topics: Mechanism of action for IL-31 inhibitor nemolizumab Clinical safety and efficacy data for nemolizumab for treatment of PN Strategies for prescribing IL-31 inhibitors in clinical practice Pearls for patient selection and addressing treatment challenges 2024-11-2633 min
DermDocsExploring the Latest Updates in the Epidermolysis Bullosa Treatment LandscapeThis is the second episode of a two-part educational series to raise awareness of epidermolysis bullosa (EB) and the latest FDA-approved treatment options for this disease. Our host, Dr. Michael Lavery, a Pediatric Dermatologist and Clinical Assistant Professor at the University of Florida in Gainesville, FL, is joined by Dr. Joyce Teng, MD, PhD, Professor of Dermatology and Pediatrics at Stanford University School of Medicine in Stanford, CA, as they discuss the following topics: Setting the stage for treating a patient with EB Assessing EB severity and subtype to inform treatment Expert review...2024-11-1532 min
DermDocsAchieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?This is the sixth episode of our ongoing "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Achieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?", featuring Beth Sweney, PA-C discusses the following topics: Challenges in achieving treatment targets in AD Therapeutic inertia and clinical implications of inadequate response Comparative clinical data evaluating upadacitinib and dupilumab for treatment of AD Transitioning to systemic therapies from topical agents, immunosuppressives, and biologic therapies 2024-11-1356 min
DermDocsExposing the Epidermolysis Bullosa Patient Burden and Challenges in Disease ManagementThis is the first episode of a two-part educational series to raise awareness of epidermolysis bullosa (EB) and the latest FDA-approved treatment options for this disease. Our host, Dr. Joyce Teng, MD, PhD, Professor of Dermatology and Pediatrics at Stanford University School of Medicine in Stanford, CA, is joined by Dr. Michael Lavery, a Pediatric Dermatologist and Clinical Assistant Professor at the University of Florida in Gainesville, FL, as they discuss the following topics: Epidemiology and prevalence of EB Burden of disease and impact on patients' quality of life Gaps and challenges for...2024-10-3132 min
DermDocsChronic Hand Eczema: All Hands on DeckThis podcast episode, sponsored by Leo Pharma, features LiVDerm faculty and esteemed dermatologists Dr. Christopher Bunick, MD, PhD, and Dr. Jonathan Silverberg, MD, PhD, MPH. As experts in all things concerning eczema, our faculty discuss the differentiating features and disease burden in patients suffering from chronic hand eczema (CHE) and review the current guidance for treatment, including these specific topics: Differentiating CHE from atopic dermatitis of the hands, including triggers, pathophysiology, and clinical presentation Expert guidance for accurate diagnosis and work-up of CHE patients Challenges and limitations of current therapeutic offerings ...2024-10-1847 min
DermDocsExamining the Gaps and Challenges in Diagnosing and Treating Prurigo NodularisThis is the first episode of a two-part miniseries, "IL-31 Inhibition for Treatment of Prurigo Nodularis" series, supported by an educational grant from Galderma and hosted by prurigo nodularis (PN) expert Dr. Shawn Kwatra, MD. This episode, "Examining the Gaps and Challenges in Diagnosing and Treating Prurigo Nodularis", featuring expert dermatologist and neuroscientist Dr. Sarina Elmariah, MD, PhD, MPH, discusses the following topics: The lack of awareness and timely, correct diagnosis of PN patients Strategies for assessing patients with PN and alleviating disease symptoms and burden Examining the current expert guidance and available...2024-09-2548 min
DermDocsSkirting Steroids in Atopic Dermatitis: New Therapies and Expert Strategies for Long-term ControlThis is the second episode of a two-part activity on "Skirting Steroids in Atopic Dermatitis", supported by an educational grant from Arcutis Biotherapeutics, Inc., and hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "New Therapies and Expert Strategies for Long-term Control", featuring expert dermatologist Dr. Jonathan Silverberg, MD, PhD, MPH, discusses the following topics: The pros and cons of steroid use in treating AD Targeted non-steroidal topical therapies approved by the FDA Relevant clinical efficacy and safety data for new and emerging non-steroidal topicals Recommendations for long-term symptom...2024-09-1659 min
DermDocsChoosing the Right Path: JAK Inhibitors or Biologics for Atopic Dermatitis?This is the fifth episode of our new "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Choosing the Right Path: JAK Inhibitors or Biologics for Atopic Dermatitis?", featuring expert dermatologist Dr. Naiem Issa, MD, PhD, discusses the following topics: Mechanistic differences between JAKi and biologics for treatment of AD Clinical data supporting the safety of JAKi in head-to-head trials compared to biologics Pearls for prescribing JAKi to AD patients Strategies for choosing JAKi vs biologics based on safety and patient...2024-09-0557 min
DermDocsSkirting Steroids in Atopic Dermatitis: Dangers and Side Effects of Steroid Exposure in Treatment of ADThis is the first episode of a two-part activity on "Skirting Steroids in Atopic Dermatitis", supported by an educational grant from Arcutis Biotherapeutics, Inc., and hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Dangers and Side Effects of Steroid Exposure in Treatment of AD", featuring expert dermatologist Dr. Peter Lio, MD, discusses the following topics: Side effects of topical and oral corticosteroid exposure Pearls and gaps in current guidelines for treatment of AD Identifying topical steroid withdrawal symptoms Safety and stewardship strategies for topical steroids Future...2024-08-1457 min
DermDocsSetting the Stage: Effective Onboarding of your AD Patients onto JAK Inhibitor TherapyThis is the fourth episode of our new "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Setting the Stage: Effective Onboarding of your AD Patients onto JAK Inhibitor Therapy", featuring expert dermatologist Dr. Ruth Ann Vleugels, MD, MPH discusses the following topics: Identifying ideal candidates for oral JAK inhibitor therapy Steps to initiate therapy and onboard new patients How to manage side effects and maintain adherence to treatment Case examples and real-world data 2024-08-0557 min
DermDocsThe Quest for Itch-Free, Clear Skin in Atopic Dermatitis: New Practice-Informing EvidenceThis is the third episode of our new "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "The Quest for Itch-Free, Clear Skin in Atopic Dermatitis: New Practice-Informing Evidence", featuring expert dermatologist Dr. Jonathan Silverberg, MD, PhD, MPH, discusses the following topics: Overall impact of atopic dermatitis on patients' quality of life Overview of the role of various existing treatments for AD and expert guidelines Discussion of LEVEL UP clinical trial data comparing upadacitinib and dupilumab Defining treatment success and best...2024-07-0350 min
DermDocsTargeted Intervention for Hidradenitis Suppurativa: Defining Window of Opportunity for Moderate-to-Severe PatientsThis special podcast episode, developed in collaboration with UCB, features LiVDerm faculty and esteemed dermatologists Dr. Jennifer Hsiao, MD, and Dr. Hadar Lev-Tov, MD. As experts in all things hidradenitis suppurativa (HS), our faculty discuss the need for early and accurate diagnosis and assessment of patients with HS in order to prescribe treatment at the best time to achieve disease control, including the following topics: Key challenges in treating patients with moderate-to-severe HS The role of targeted, systemic therapies in HS management Defining "moderate" disease and strategies for severity assessment Defining...2024-05-3038 min
DermDocsJAK Inhibitors in Action: Effectiveness in Atopic DermatitisThis is the second episode of our new "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "JAK Inhibitors in Action: Effectiveness in Atopic Dermatitis", featuring expert dermatologist Dr. James Song, MD, discusses the following topics: Short- and long-term efficacy and safety data for JAK inhibitor therapies New topline data from the LEVEL UP trial studying upadacitinib in comparison to dupilumab for the treatment of patients aged 12 years and older with moderate-to-severe AD Head-to-head studies and real-world evidence evaluating JAK inhibitor therapies E...2024-05-2947 min
DermDocsPsoriasis in Skin of Color Unplugged: Patient and Disease AdvocacyThis is the fourth and final episode of the, "Psoriasis in Skin of Color Unplugged" series, hosted by expert dermatologist Dr. Mona Shahriari who will be discussing the gaps in care for psoriasis patients with skin of color. This episode, “Patient and Disease Advocacy”, featuring Jason Harris, the VP of Government Relations and Advocacy at the National Psoriasis Foundation (NPF), discusses the following topics: Patient perspective on challenges to receiving treatment for their psoriasis NPF efforts to address patient challenges and access to care issues Relevant survey and research data on disparities specific to SoC...2024-05-2130 min
DermDocsPsoriasis in Skin of Color Unplugged: Advancing Diversity and Inclusion in Clinical TrialsThis is the third episode of the, "Psoriasis in Skin of Color Unplugged" series, hosted by expert dermatologist Dr. Mona Shahriari who will be discussing the gaps in care for psoriasis patients with skin of color. This episode, “Advancing Diversity and Inclusion in Clinical Trials”, featuring expert dermatologists Dr. Andrew Alexis and Dr. Jennifer Soung, discusses the following topics: Underrepresentation of diverse patients, investigators, and trial sites in clinical studies FDA efforts to improve clinical trial diversity and education The impact that current clinical trials focusing on SOC are having on patient care...2024-05-1438 min
DermDocsPsoriasis in Skin of Color Unplugged: Gaps in Diagnosis and Dermatologist TrainingThis is the second episode of the, "Psoriasis in Skin of Color Unplugged" series, hosted by expert dermatologist Dr. Mona Shahriari who will be discussing the gaps in care for psoriasis patients with skin of color. This episode, “Gaps in Diagnosis and Dermatologist Training”, featuring expert dermatologist Dr. George Han, discusses the following topics: Difference in clinical presentation of psoriasis in SoC Barriers to early and accurate diagnosis and dangers of delayed diagnosis Gaps in medical student and residency education Lack of SoC images in medical textbooks, public images, and advertising...2024-05-0726 min
DermDocsPsoriasis in Skin of Color UnpluggedThis is the first episodes of a new series, "Psoriasis in Skin of Color Unplugged", hosted by expert dermatologist Dr. Mona Shahriari who will be discussing the gaps in care for psoriasis patients with skin of color. This episode, “Disparities and Access to Care”, featuring expert dermatologist Dr. Candrice Heath, discusses the following topics: Increased severity of psoriatic disease in patients of color Challenges associated with access to specialist care Stigma surrounding psoriasis in patients of color Gaps in culturally competent care www.LiVDerm.org2024-04-3023 min
DermDocsThe Spectrum of Atopic Dermatitis and the Emerging Role of JAK Inhibitors This is the first episodes of a new series hosted by expert dermatologist Dr. Christopher Bunick who will be discussing the evolving role of JAK inhibitor therapies in the management of atopic dermatitis (AD). This episode, "The Spectrum of Atopic Dermatitis and the Emerging Role of JAK Inhibitors", featuring expert dermatologist Dr. John Koo, discusses the following topics: Understanding atopic dermatitis as a spectrum disorder, phenotypes and endotypes, and heterogeneity of atopic disease Summarizing JAK inhibitor therapies, including clinical safety and efficacy and mechanism of action Comparison of JAKi to biologics and traditional systemic agents, and the evolving role of...2024-04-2448 min
DermDocsEczema Awareness Month with Christopher Bunick, MD, PhDn support of Eczema Awareness Month, LiVDerm sat down with one of the nation’s top experts on atopic dermatitis, Christopher G. Bunick, MD, PhD, to discuss this widespread skin condition that affects millions worldwide. Associate professor of dermatology at Yale University School of Medicine, Dr. Bunick covers emerging targeted therapies and also looks at the concerns over their safety and efficacy. He also addresses some of the gaps that persist in treatment despite these new therapies. 2023-10-2528 min
DermDocsEczema Awareness Month with Peter Lio, MDIn support of Eczema Awareness Month, LiVDerm sat down with one of the nation’s top experts on atopic dermatitis, Peter A. Lio, MD, to discuss this widespread skin condition that affects millions worldwide. Dr. Lio, a clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, focuses on caring for pediatric patients with eczema in his interview. He provides unique insight into how best to combine integrative and pharmacologic treatments. 2023-10-2510 min
DermDocsAssessing and Addressing Comorbid Conditions in Alopecia Areata with Natasha A. Mesinkovska, MD, PhDNatasha A. Mesinkovska, MD, PhD, who spoke on the live satellite symposium "Gamechangers in Alopecia Areata" at the SBS 2023 meeting, speaks out about comorbid conditions often seen in alopecia areata patients, as well as her personal approach to treatment. Questions: We’ve heard a lot about comorbid conditions often seen in patients with alopecia areata. Do you have any pearls you’d like to share regarding screening or multidisciplinary care for patients with comorbidities? What is your personal approach to developing a treatment plan for your patients with alopecia areata? Thank you f...2023-04-2803 min
DermDocsUpdates in JAK Inhibitor Therapies for Alopecia Areata with Brett King, MD Brett King, MD, PhD, who spoke on the live satellite symposium "Gamechangers in Alopecia Areata" at the SBS 2023 meeting, speaks out about the rising use of JAK inhibitors to treat patients with alopecia areata. Questions: JAK inhibitors are taking the dermatology field by storm, with several approvals for multiple dermatologic conditions over the past couple of years. What is it that makes JAK inhibitors a gamechanger for treatment of alopecia areata? In 2022, the first ever targeted treatment for alopecia areata, baricitinib, was approved by the FDA for adult patients. What additional treatments or F...2023-04-2803 min
DermDocsNuanced Treatment of Pediatric Alopecia Areata with Brittany Craiglow, MDBrittany Craiglow, MD, who spoke on the live satellite symposium "Gamechangers in Alopecia Areata" at the SBS 2023 meeting, shares her personal approach to treating pediatric patients with alopecia areata. Questions: What is your personal approach to developing a treatment plan with your patients and/or their caregivers? Do find yourself utilizing shared decision-making or other nuances to communicating with patients and caregivers? You mainly treat pediatric and adolescent patients for hair loss in your clinical practice. Are there any specific nuances you’d like to share in regard to treating pediatric versus adult pa...2023-04-2804 min
DermDocsNavigating the Expanding Treatment Landscape for Pediatric Patients with Atopic DermatitisElaine Siegfried, MD, who spoke on the live satellite symposium "Infants and Atopic Dermatitis" at the MOPD 2023 meeting, shares her expert advice for formulating a treatment plan and incorporating newer treatment options when managing pediatric patients with atopic dermatitis. Questions: With recently expanded age indications for therapeutic agents to treat pediatric AD, what steps should clinicians consider when formulating a treatment plan for their younger patients? The treatment landscape for atopic dermatitis in pediatric patients has shown much growth over the past couple of years. How do you foresee the treatment landscape continuing to change in 2023? T...2023-04-2603 min
DermDocsPearls for Early and Accurate Diagnosis of Infantile Atopic DermatitisLawrence Schachner, MD, chair of the MOPD meeting and expert faculty who spoke on the live satellite symposium "Infants and Atopic Dermatitis", shares clinical pearls for early and accurate diagnosis of atopic dermatitis in younger pediatric patients, as well as challenges often faced when assessing pediatric patients with skin of color. Questions: Can you share your top pearls for early and accurate recognition of atopic dermatitis in infants? What gaps do you feel persist in the diagnosis and assessment of atopic dermatitis in infants, particularly those with skin of color? Thank you for your time today, D...2023-04-2602 min
DermDocsImproving Communication and Shared Decision-Making with Caregivers of Patients with Atopic DermatitisMercedes Gonzalez, MD, who spoke on the live satellite symposium "Infants and Atopic Dermatitis" at the MOPD 2023 meeting, shares clinical pearls for improving communication with patients and caregivers of patients with atopic dermatitis. Questions: Caregivers often voice concerns regarding safety and side effects of newer systemic treatments for atopic dermatitis. What can clinicians do to better educate and reassure their patients and caregivers? How does shared decision-making factor into this? What gaps do you feel persist regarding the communication between clinicians and their patients/caregivers? What can clinicians do to address these gaps? Thank you for...2023-04-2603 min
DermDocsDeeper than the Surface of SkinLiVDerm is very excited to announce our two Co-Chairs for the 21st Annual South Beach Symposium (SBS) meeting, taking place in 2023, Dr. Michael Gold, MD and Dr. David Goldberg, MD, JD. Our theme, Deeper Than the Surface, was born based on what sets SBS apart from any of the other hundreds of dermatology meetings out there and that's how SBS truly delivers equal parts Clinical and Aesthetic Dermatology Education. Both Dr. Gold and Dr. Goldberg have been a part of SBS since its inception 21 years ago, and they have evolved with the meeting. Although many...2022-11-1609 min
DermDocsPeter Lio, MD - August 11, 2022 - The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic DermatitisPeter Lio, MD, LiVDerm faculty and atopic dermatitis expert, shares pearls from his session at the SBS 2022 event regarding the efficacy and safety of IL-13 inhibitors for treatment of AD. What factors should clinicians consider when selecting a biologic or systemic therapy to manage atopic dermatitis? Effectively and promptly diagnosing atopic dermatitis can be a bit tricky at times. What is your personal approach for effective diagnosis? Which patients would benefit most from an integrative approach to managing atopic dermatitis? How can clinicians execute effective shared decision-making strategies in the management of chronic skin conditions? 2022-09-2005 min
DermDocsChristopher Bunick, MD, PhD - August 11, 2022 - The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic DermatitisChristopher Bunick, MD, PhD, LiVDerm faculty and member of the SBS Planning Committee, shares key takeaways from his session at the SBS 2022 event regarding IL-13 inhibitors for treatment of AD and the underlying disease pathogenesis. With the several ongoing advances in the availability of more treatment options for managing atopic dermatitis, how can the practicing clinician best select the most appropriate treatment option that will address the underlying causes of disease progression? As with most treatment options for chronic conditions, side effects often occur. What considerations should clinicians remember when discussing treatment-related adverse events with their p...2022-09-2005 min
DermDocsDermatologic Care in the Sexual + Gender Diverse Patient with Klint Peebles, MDWe are honored to speak to Klint Peebles, MD, the chair of LiVDerm's Sexual and Gender Diverse Dermatology Summit: Fundamentals and Practical Pearls and past chair of the American Academy of Dermatology’s Expert Resource Group on Sexual and Gender Diverse Health. Dr. Peebles, a board-certified dermatologist with Kaiser Permanente, Mid-Atlantic Permanente Medical Group, has extensive clinical, leadership, and research expertise in sexual and gender diverse health and gender-affirming dermatology. Dr. Peebles currently serves on the LGBTQ Health Specialty Section Council of the American Medical Association. Dr. Peebles mentions some of the key reasons why you don't want to mi...2022-08-0327 min
DermDocsThe Latest Advances in Cosmetic Dermatology with Doris J. Day, MDInternationally renowned dermatologist, Doris Day, MD, who recently was named one of the top 5 dermatologists in America for 2022, gives us the latest updates in aesthetic and medical dermatology. She also mentions some of the key reasons why you don't want to miss the upcoming South Beach Symposium in Miami, FL - and SBS West in California! Dr. Day specializes in laser, cosmetic and surgical dermatology. She lectures nationally and internationally on the latest aesthetic techniques to both her peers and to the public. As a highly respected and sought-after personality in the area of cosmetic d...2022-07-1114 min
DermDocsRedefining Perfection, with Jason J. Emer, MDPlease listen as nationally-renowned innovator, artist, and scientist, Jason J. Emer, MD, shares the secrets to redefining perfection. Dr. Emer is well-known throughout the nation as the master of his field. He is redefining the world of liposuction and body shaping, one impeccably-sculpted client at a time. Dr. Emer pushes the boundaries of what’s possible – earning him a well-deserved reputation as the man behind some of Beverly Hills’ most notorious bodies. This is a must-listen episode! Don't forget to rate, subscribe or follow DermDocs, and leave us a five star review!2022-06-2725 min
DermDocsThe Latest Advances with Energy-Based Devices and Scar Treatments with Michael H. Gold, MD, FAADListen as world-renowned dermatologist, Michael H. Gold, MD, FAAD, gives us great insight on energy-based devices, and how they treat a myriad of skin conditions. He also uncovers the latest advances in scar treatment. It's an episode you won't want to miss! Dr. Gold is a board-certified dermatologist and dermatologic surgeon. He is world-renowned for providing patients with leading-edge technological advances in dermatology. He was also recently named one of the top three dermatologists in Nashville. Don't forget to rate, subscribe or follow DermDocs, and leave us a five star review! Topics he...2022-06-1416 min
DermDocsAnatomy Matters: The Cadaver Lab Experience with Z. Paul Lorenc, MDDr. Z. Paul Lorenc, M.D., shares insights about cellulite protocols, facial structure techniques, and important information about why you should attend his live cadaver workshop this fall. Other topics he covers in this part 2 special include: When deciding how to manage cellulite, which patient characteristics do you consider most strongly when selecting a course of treatment? Why is an understanding of facial anatomy so important, particularly in the lower face and jaw, for providers when selecting injection patterns? You may know that South Beach Symposium is expanding to the West Coast this Fall. Because you practice...2022-05-3112 min
DermDocsDermDocs Podcast | Skin Cancer Prevention and Latest Advancements in Dermatology with Dr GoldbergListen as internationally known dermatologist, David Goldberg, M.D., J.D., gives us insight into how to prevent skin cancer - as well as shares some of the latest and greatest advancements in dermatology in part 2 of his podcast series. Dr. Goldberg is known for his work using cutaneous lasers and other noninvasive facial and body rejuvenation techniques. He is active in clinical practice as the director of Skin Laser & Surgery Specialists of New York and New Jersey, and as a clinical professor of dermatology at Mount Sinai School of Medicine and Rutger’s New Jersey Medical School. ...2022-05-1708 min
DermDocsLive Patient Injections for Skin Rejuvenation with David Goldberg, M.D., J.D.Listen as internationally known dermatologist, David Goldberg, M.D., J.D., gives us some of the latest tips and tricks about skin rejuvenation in this part I podcast special. Dr. Goldberg is known for his work using cutaneous lasers and other noninvasive facial and body rejuvenation techniques. He is active in clinical practice as the director of Skin Laser & Surgery Specialists of New York and New Jersey, and as a clinical professor of dermatology at Mount Sinai School of Medicine and Rutger’s New Jersey Medical School. Don't forget to rate, subscribe or follow DermDocs, and...2022-05-0208 min
DermDocsFinding the Fountain of Youth: How Light Keeps Your Skin GlowingListen as Patrick Bitter Jr., MD, FAAD shares insights about why light is so important when it comes to keeping your skin healthy. You don't want to miss these tips from Dr. Bitter - who was just featured in the cover story of Top Doctor Magazine 's March 2022 issue for his discovery of pulsed light and its usefulness, effectiveness, and versatility in treating a multitude of skin problems, as well as delaying skin aging, and maintaining healthy skin, as an adjunct to a cosmetic surgical practice in the treatment of post surgical scars - in other words, finding the "...2022-04-1823 min
DermDocsScience is your guide. Anatomy is your savior with Dr LorencDr. Z. Paul Lorenc, M.D., shares insights about why science is your guide and anatomy is your savior. He will be leading the hands-on cadaver workshop at the South Beach Symposium this August, and you don't want to miss it! Other topics he covers include: Why is a mastery of facial anatomy principles non-negotiable for cosmetic dermatologists who offer soft tissue fillers? Can you explain the basic differences between facial fillers and neurotoxins - and how to use both injectables in the same patient successfully? You'll lead the intensive Hands-On Cadaver Workshop at the 2022 South Beach S...2022-04-0411 min
DermDocsDermatology, Longevity, and Overall Health with Dr Doris DayDr. Doris Day, M.D., F.A.A.D., M.A. shares insights about the latest trends and new developments in dermatology today.2022-03-2115 min
DermDocsThe Latest Developments in Dermatology with Dr Glynis AblonDr. Glynis Ablon, M.D., F.A.A.D. shares some insightful knowledge about the latest developments in dermatology and how to keep your patients feeling confident and vivacious, including: As a member of the South Beach Symposium Planning Committee, you help design and curate the agenda. How do you decide which topics should be covered; do you rely on issues or concerns you see in your practice, or emerging therapeutics/devices/technologies? In your opinion, is it more beneficial for dermatologists to have either a cosmetic, medical, or surgical practice an...2022-03-0707 min
DermDocsEmerging Treatments in Dermatology with Dr KatzDr. Bruce Katz, MD, shares some emerging treatments in dermatology including: The global facial injectables market size is expected to reach USD 9.07 billion by 2028 (the market size stood at USD 4.46 billion in 2020): What does this mean for aesthetic medicine providers, are there more ways to capitalize on this growth other than simply offering injectables? Which new or emerging laser technology or treatment should providers have their eyes on, or consider offering in their practice if they don’t already? For someone interested in facial rejuvenation but hesitant to commit to surgery, which noninvasive or m...2022-02-2308 min
DermDocsThe Latest Updates on Treating Atopic Dermatitis with JAK Inhibitors with Dr Brett KingBrett King, MD, LivDerm faculty and a pioneer in utilizing JAK inhibitor therapy for treating atopic dermatitis discusses the best ways recently approved JAK inhibitors can be used in your clinical toolbox.2022-02-1707 min
DermDocsTreating Atopic Dermatitis in Pediatric Patients with Dr Peter LioDr. Peter Lio, MD, shares some highlights about the treatment of atopic dermatitis in pediatric patients including: Can you tell us about the number of emerging therapies for the treatment of atopic dermatitis in pediatric patients and how this has changed the treatment landscape? What is your personal approach to treating atopic dermatitis in pediatric patients? What made you decide to found the Chicago Integrative Eczema Center to prevent atopic dermatitis in children? Can you share some advice for dermatologists on communicating with parents and caretakers of pediatric atopic dermatitis patients...2022-02-0921 min
DermDocsTakeaways Regarding Disparities in the Treatment of Atopic Dermatitis and Scalp/Hair Conditions in Pediatric Patients with Skin of ColorCandrice Heath, MD, discusses key takeaways regarding disparities in the treatment of atopic dermatitis and scalp/hair conditions in pediatric patients with skin of color, including: Can you highlight some of the systemic issues that contribute to a lack of knowledge about atopic dermatitis in patients of color, particularly in the pediatric patient population? (This is in reference to lack of diversity in clinical trials, lack of training involving skin of color, etc.) Can you discuss some of the more common hair and scalp conditions seen in pediatric patients of color, and why they are more commonly seen...2021-05-0614 min
DermDocsClinical Pearls from Regarding the Treatment of Acne Patients with Skin of ColorSusan Taylor, MD, shares some clinical pearls from regarding the treatment of acne patients with skin of color, including: Can you highlight some of the systemic issues that contribute to a lack of knowledge about acne in patients of color? (This is in reference to lack of diversity in clinical trials, lack of training involving skin of color, etc.) Can you explain why it is important to treat post-inflammatory hyperpigmentation alongside acne, particularly in patients of color? Are there any unique considerations that must be taken when prescribing treatment for acne patients with skin of color? Can you...2021-05-0606 min
DermDocsTreatment of Atopic Dermatitis and Psoriasis in Patients with Skin of ColorAndrew Alexis, MD, shares some highlights regarding the treatment of atopic dermatitis and psoriasis in patients with skin of color, including: Can you highlight some of the systemic issues that contribute to a lack of knowledge about acne in patients of color? (This is in reference to lack of diversity in clinical trials, lack of training involving skin of color, etc.) Can you explain why certain skin conditions, including atopic dermatitis and psoriasis, may be more difficult to diagnose in patients with skin of color? What is your personal approach to treating atopic dermatitis patients with skin of...2021-05-0609 min
DermDocsCurrent Health Disparities in Dermatologic Care for Patients with Skin of ColorAmy McMichael, MD, Chair of the LiVDerm Deep Dive Racial Disparities in Dermatology program, shares highlights the current health disparities in dermatologic care for patients with skin of color, including: Can you give us a brief overview of the LiVDerm Deep Dive Racial Disparities program and why it is important to dermatologists? Can you highlight some of the systemic issues that specifically contribute to a lack of knowledge about dermatologic conditions in patients of color? Have you seen a change in the representation of patients with skin of color in clinical trials? Where do you feel dermatologists can c...2021-05-0606 min
DermDocsNew and Emerging TherapiesMark Lebwohl, MD, discusses the new and emerging therapies for treatment of psoriasis, including: Can you elaborate on the different classes of biologics currently indicated for treatment of psoriasis? What are some of the most promising therapies that will likely be part of the psoriasis treatment table in the near future? Do you foresee that they will be also approved for pediatric psoriasis patients, or only for the adult population? Where do you feel biologics fit in with the other approved treatments for psoriasis, or overall in the treatment regimen? Can you tell us what you...2021-04-1407 min
DermDocsClinical Pearls About Treatment of PsoriasisAdelaide Hebert, MD, shares some highlights and clinical pearls about treatment of psoriasis in pediatric patients, including: What is your personal approach to treating psoriasis in pediatric patients compared to other age groups? Can you highlight the different class of therapeutics currently indicated to treat pediatric patients with psoriasis? Are there any considerations to be made when prescribing treatment for psoriasis in patients across the age spectrum, from infants to adolescents? How do you educate patients and families to deal with the psychological aspects of psoriasis, as well as with treatment adherence? 2021-04-1407 min
DermDocsManagement of Atopic Dermatitis in Pediatric Patients with Skin of ColorLatanya Benjamin, MD, shares clinical pearls about the management of atopic dermatitis in pediatric patients with skin of color, including: Can you tell us about the number of emerging therapies for treatment of AD in pediatric patients and how this will change the treatment landscape? What is your personal approach to treating AD in pediatric patients with skin of color? Can you share some advice for dermatologists on communicating with parents and caretakers of pediatric AD patients regarding treatment options and at-home interventions? 2021-04-0908 min
DermDocsRecent Developments in the Pediatric Atopic Dermatitis Treatment LandscapeLawrence Schachner, MD, discusses recent developments in the pediatric atopic dermatitis treatment landscape, including: Can you share some advice for dermatologists on communicating with parents and caretakers of pediatric AD patients regarding treatment options and at-home interventions? Dupilumab is currently approved for patients with atopic dermatitis aged 6 years and older. Do you foresee dupilumab being approved for even younger patients in the near future? How do emerging JAK inhibitors fit into the existing treatment landscape for pediatric patients with atopic dermatitis? 2021-04-0905 min
DermDocsPediatric Skin of Color SymposiumCandrice Heath, MD, shares some highlights from the Pediatric Skin of Color Symposium about the treatment of acne in pediatric patients with skin of color, including: What is your personal approach to treating acne in patients with skin of color? Can you tell us about the approved and emerging therapies for treatment of acne in pediatric patients? Have any of them been studied in patient populations with skin of color? Can you explain why it is important to treat both acne and post-inflammatory hyperpigmentation, particular in patients of color? How do...2021-04-0906 min
DermDocsPediatric Skin of Color SymposiumLatanya Benjamin, MD, shares some highlights from the Pediatric Skin of Color Symposium at MOPD about the treatment of atopic dermatitis in pediatric patients with skin of color, including: Can you tell us about the number of emerging therapies for treatment of AD in pediatric patients and how this will change the treatment landscape? What is your personal approach to treating AD in pediatric patients with skin of color? Can you share some advice for dermatologists on communicating with parents and caretakers of pediatric AD patients regarding treatment options and at-home interventions? 2021-04-0908 min
DermDocsDiversity in Derm Treatments: Skin of ColorAmy McMichael, MD, Chair of the CME Symposium "Diversity in Derm Treatments: Skin of Color" at SBS 2021, leads a panel discussion with Valerie Callender, MD, and Seemal Desai, MD, to share clinical pearls and key takeaways about treatment of dermatologic conditions in patients with skin of color.2021-04-0910 min
DermDocsPatient InterviewGlenn Speer, PhD, has been working with dermatologists to manage his psoriatic arthritis symptoms for over 20 years. In this video interview, Glenn tells his story, including: Can you share with us your experience of your path to diagnosis? Can you tell us about what type of treatments you tried and how long and how long it took you to identify the best treatment? Can you share more with us about how PsA has affected both your personal and professional life? Do you have a message that you'd like to convey to...2021-04-0907 min
DermDocsTime to Think About Both Skin and Joint DiseaseAlice Gottlieb, MD, Chair of the CME symposium "Time to Think About Both Skin and Joint Disease: Optimizing the Diagnosis and Management of Psoriatic Arthritis" at SBS 2021, shares some clinical pearls about the dermatologist's role in screening and diagnosing psoriatic arthritis, including: Can you tell us about screening tools that are currently available for psoriatic arthritis patients? What is your personal approach to diagnosing psoriatic arthritis patients? What do you feel the dermatologist’s role is in treatment of psoriatic arthritis? Do you have any advice for dermatologists working with rheumatologists as a te...2021-04-0904 min
DermDocsTreatment of Acne and Antibiotic Stewardship in Pediatric PatientsLawrence Schachner, MD, shares some clinical pearls about treatment of acne and antibiotic stewardship in pediatric patients, including: What do dermatologists need to keep in mind when prescribing treatments for pediatric patients with acne? How do these new acne treatments address the issue of antibiotic resistance? Can you tell us more about the effects of these new acne treatments on the microbiome? 2021-04-0904 min
DermDocsTreatment of Acne and Antibiotic StewardshipDiane Berson, MD, shares additional clinical pearls on the treatment of acne and antibiotic stewardship, including: Can you discuss how the microbiome is affected in treatment of acne patients? Can you explain which antibiotics are better in terms of resistance? What are the core principles of antibiotic stewardship? What is your personal approach to minimizing antibiotic resistance in acne? 2021-04-0804 min
DermDocsTreatment of Acne in Preteen PatientsJonette Keri, MD, shares some highlights about treatment of acne in preteen patients, including: What is your personal approach to treating acne in preteen patients compared to other age groups? What is your advice for dermatologists to keep in mind when treating preteen patients with acne? Can you tell us more about the efficacy and safety of these new acne medications for children and adolescents? How do you educate patients and families to deal with the psychological aspects of acne, as well as with treatment adherence? 2021-04-0808 min
DermDocsNew and Emerging Therapies for Treatment of Acne PatientsJames Del Rosso, DO, discusses new and emerging therapies for treatment of acne patients, including: What is your personal approach for exploring alternative treatments for acne patients beyond first-line therapies? Can you compare the emerging topical treatments for acne? What are some advantages with the newer topical retinoids? How do these new acne treatments address the issue of antibiotic resistance? 2021-04-0814 min
DermDocsTreatment of Acne in Pediatric Patients with Skin of ColorCandrice Heath, MD, shares clinical pearls about the treatment of acne in pediatric patients with skin of color, including: What is your personal approach to treating acne in patients with skin of color? Can you tell us about the approved and emerging therapies for treatment of acne in pediatric patients? Have any of them been studied in patient populations with skin of color? Can you explain why it is important to treat both acne and post-inflammatory hyperpigmentation, particular in patients of color? How do you educate patients and families...2021-04-0806 min
DermDocsEVOLVING PARADIGMS IN ATOPIC DERMATITISFernanda Schmidt, MD shares some clinical pearls about the evolving paradigms in AD, including: What are the inside-out and outside-in mechanisms of AD? Is there a difference between these mechanisms across the age spectrum – from children to adults? Can we halt the atopic march by repairing the skin, or is it more than “skin deep”? 2020-07-2707 min
DermDocsPERSPECTIVES ON EMERGING AD THERAPIESLeon Kircik, MD discusses the potential role of emerging AD treatments, including: Why has atopic dermatitis lagged behind compared to psoriasis in terms of approved targeted treatments? What are some of the most promising therapies that will likely be part of the AD treatment table in the near future? Do you foresee that they will be also approved for pediatric AD, or only for the adult population? In terms of assessing disease severity, how practical are the scales used in clinical trials? Should we put more emphasis on patient-reported outcomes? 2020-07-2711 min
DermDocsPEARLS ON INTEGRATING NEWER AD TREATMENTSLawrence Schachner, MD discusses clinical pearls on the diagnosis and treatment of pediatric AD, including: How do we make sure that we correctly diagnose atopic dermatitis? What are some clinical pearls you can share for our audience? Since now dupilumab is approved for children with atopic dermatitis, what is its role and where would it fit into the “Schachner ladder”? How do crisaborole and dupilumab fit into the long-term care of AD? For how long should they be used? 2020-07-2708 min
DermDocsTHE PROMISE OF JAK INHIBITORS IN ADNeal Bhatia, MD discusses the potential role of JAKis in AD, including: What changes would JAKis bring to the treatment of AD in the near future? What are some JAKis currently under clinical development for AD? Do you foresee that JAKis will play a role in both adult and pediatric AD? Where do you think they will fit in with the other recently-approved treatments for AD, or overall in the treatment regimen? What are the long-term implications for dermatology practice? 2020-07-2709 min
DermDocsAcne Treatment Across the LifespanJonette Keri, MD, PhD, shares some highlights about acne evaluation and treatment across the age spectrum, including: • How do we differentiate and grade acne across the age spectrum, from newborns to preteens? • When is it necessary to refer, particularly to endocrinology or other specialties, for childhood acne that may be associated with an underlying endocrine disorder? • What should we be using more of and less of in treating acne across the age groups? • How do you educate patients and families to deal with the psychological aspects of acne, as well as with tre...2020-07-2714 min
DermDocsAdult female acneDiane Berson, MD, shares additional clinical pearls on the treatment of adult female acne, including: • What are some typical acne presentations seen in adult women? • Can acne in women persist beyond menopause? • Can some of the newer non-oral contraceptives exacerbate acne flares? What are the options in this case? • Is there a concern with hyperkalemia in patients taking spironolactone for acne? • What should dermatologists keep in mind while treating acne in adult women?2020-07-2706 min
DermDocsCONTROVERSIES AND NOVEL THERAPIES FOR ACNEJames Del Rosso, MD, shares clinical pearls about common controversies and recent developments in acne therapy, including: What is your approach to minimizing antibiotic resistance in acne? Are the newer antibiotics better in terms of resistance? Why are dermatologists hesitant in using oral isotretinoin? What are some of the advantages with the newer topical retinoids? Should we pay more attention to truncal acne? 2020-07-2716 min
DermDocsADVANCES IN LASER AND LIGHT THERAPIESMichael Gold, MD, discusses additional takeaways on laser and light therapy for acne, including: How do you explain the absence of light and laser therapies from the global alliance acne treatment algorithm? Do you think that there is enough evidence to recommend their addition to the treatment guidelines? How do lasers/light therapies for acne challenge the current treatment status quo? How do they fit in with existing treatments? For what patient profiles (in terms of severity or type of acne) are they more appropriate? What are some key devices for acne treatment? 2020-07-2708 min